MCA-derived MSC therapy in renal transplant recipients

2024-512553-25-00 Human pharmacology (Phase I) - Other Ongoing, recruiting

Start 15 Oct 2024 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Ongoing, recruiting
Participants planned 16
Countries 1
Sites 1

Rejection transplanted kidney

Key facts

Sponsor
Leids Universitair Medisch Centrum (LUMC)
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Phenomena and Processes [G] - Immune system processes [G12]
Trial duration
15 Oct 2024 → ongoing
Decision date (initial)
2024-09-30
Transition trial
Yes
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2024-512553-25-00
EudraCT number
2022-004168-11

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Rejection transplanted kidney

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Leids Universitair Medisch Centrum (LUMC)

Sponsor organisation
Leids Universitair Medisch Centrum (LUMC)
Address
Albinusdreef 2
City
Leiden
Postcode
2333 ZA
Country
Netherlands

Scientific contact point

Organisation
Leids Universitair Medisch Centrum (LUMC)
Contact name
H.S. Spijker

Public contact point

Organisation
Leids Universitair Medisch Centrum (LUMC)
Contact name
Clinical Research Unit Internal Medicine

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Netherlands Ongoing, recruiting 16 1
Rest of world 0

Investigational sites

Netherlands

1 site · Ongoing, recruiting
Leids Universitair Medisch Centrum (LUMC)
Nephrology, Albinusdreef 2, 2333 ZA, Leiden

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Netherlands 2024-10-15 2024-10-15

Application history

3 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-08-19 Netherlands Acceptable with conditions
2024-09-30
2024-09-30
2 NON SUBSTANTIAL MODIFICATION NSM-1 2025-08-25 Netherlands Acceptable with conditions
2024-09-30
2025-08-25
3 NON SUBSTANTIAL MODIFICATION NSM-2 2025-12-08 Netherlands Acceptable with conditions
2024-09-30
2025-12-08